Discontinuation report VINORELBINE TARTRATE FOR INJECTION
Report ID | 88619 |
Drug Identification Number | 02271214 |
Brand name | VINORELBINE TARTRATE FOR INJECTION |
Common or Proper name | VINORELBINE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | VINORELBINE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5ML |
ATC code | L01CA |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2019-09-15 |
Actual discontinuation date | |
Remaining supply date | 2019-09-15 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-05 | English | Compare |
v2 | 2019-07-05 | French | Compare |
Showing 1 to 2 of 2